Enantioselective Sulfonimidamide Acylation via a Cinchona Alkaloid-Catalyzed Desymmetrization: Scope, Data Science, and Mechanistic Investigation
Authors:
- Brittany HaasBHBrittany Haas
- Ngiap-Kie LimNLNgiap-Kie Lim
- Janis JermaksJJJanis Jermaks
- Eden GasterEGEden Gaster
- Melody GuoMGMelody Guo
- Thomas MaligTMThomas Malig
- Jacob WerthJWJacob Werth
- Haiming ZhangHZHaiming Zhang
- F. Dean TosteFTF. Dean Toste
- Francis GosselinFGFrancis Gosselin
- Scott MillerSMScott Miller
- Matthew SigmanMSMatthew Sigman
Preprint
- 9 January 2024
- preprint
- Published by American Chemical Society (ACS) in ChemRxiv
Abstract
Methods to access chiral sulfur (VI) pharmacophores are of interest in medicinal and synthetic chemistry. We report the desymmetrization of unprotected sulfonimidamides via asymmetric acylation with a cinchona-phosphinate catalyst. The desired products are formed in excellent yield and enantioselectivity with no observed bis-acylation. A data science-driven approach to substrate scope evaluation was coupled to high throughput experimentation (HTE) to facilitate statistical modeling in order to inform mechanistic studies. Reaction kinetics, catalyst structural studies, and density functional theory (DFT) transition state analysis elucidated the turnover-limiting step to be the collapse of the tetrahedral intermediate and provided key insights into the catalyst-substrate structure-activity relationships responsible for the origin of enantioselectivity. This study offers a reliable method for accessing enantioenriched sulfonimidamides to propel their application as pharmacophores and serves as an example of the mechanistic insight that can be gleaned from integrating data science and traditional physical organic techniques.Keywords
All Related Versions
Funding Information
- National Institutes of Health (R35 GM136271)
- National Institutes of Health (NIGMS R35 132092)
- National Institutes of Health (R35 GM118190)
This publication has 29 references indexed in Scilit:
- Progress in the Enantioselective Synthesis of Sulfur (VI) CompoundsChemistry – A European Journal, 2023
- Crafting chemical space with sulfur functional groupsTrends in Chemistry, 2022
- Sulfonimidamides in Medicinal and Agricultural ChemistryAngewandte Chemie International Edition, 2017
- Variable Time Normalization Analysis: General Graphical Elucidation of Reaction Orders from Concentration ProfilesAngewandte Chemie International Edition, 2016
- Preclinical Characterization of Acyl Sulfonimidamides: Potential Carboxylic Acid Bioisosteres with Tunable PropertiesChemMedChem, 2015
- A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound, administered as a 24-h continuous infusion in patients with advanced solid tumorsCancer Chemotherapy and Pharmacology, 2012
- A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumorsCancer Chemotherapy and Pharmacology, 2011
- Direct Organocatalytic Asymmetric α‐Sulfenylation of Activated C-H Bonds in Lactones, Lactams, and β‐Dicarbonyl CompoundsChemistry – A European Journal, 2005
- Reaction Progress Kinetic Analysis: A Powerful Methodology for Mechanistic Studies of Complex Catalytic ReactionsAngewandte Chemie International Edition, 2005
- Rate-determining collapse of a tetrahedral intermediate in ester aminolyses in aprotic solventsTetrahedron Letters, 1970